Watson for Genomics From IBM Enters First European Hospital in Switzerland

The Hôpitaux Universitaires Genève in Switzerland will become the first university hospital in Europe to install IBM’s artificial intelligence for the purpose of aiding doctors in helping patients with advanced cancer symptoms.  

According to a man known as Rodolphe Meyer, who is also the person who manages the IT department at the Hôpitaux Universitaires, one should not expect the IBM artificial intelligence tool to replace medical practitioners anytime soon, but will likely save them precious time when it comes down to locating the best treatment.  

We understand that doctors at this Swiss hospital tend to test cancer patients DNA in a bid to come up with a treatment that best fit their unique cases.  

“It usually takes hours to analyze results the traditional way, searching for literature and data on the different treatments that are available,” says Meyer in a recent interview. “Watson for Genomics can provide this info in 15 minutes. Clinicians can then use the time to be more precise in what they choose for their patients.”  

LabioTech

We have to say, Watson for Genomics is a pretty solid product, and not surprising since it comes directly from IBM. The company has been working on this project for years, and it is finally proving useful in real-world scenarios. 

Understand that this artificial intelligence tool from IBM is capable of reading through genomics databases and scientific writings with the primary purpose of providing doctors with the best treatments for cancer patients and their specific needs.  

The research and the results are all based on the patient’s DNA; therefore, Watson for Genomics must be precise in the best way possible.  

Now, the software isn’t particularly new to hospitals, just in Europe at this time. You see, IBM had introduced Watson for Genomics in North America and Asia in the past, and so far, it’s working wonders in those territories.  

For now, only time will tell if artificial intelligence is good enough to help doctors make important decisions that will no doubt affect patients. Lives are at risk if these tools recommend the wrong procedure, and a doctor chooses to follow. 

More Stories
State of Decay 2’s $29.99 Price Could Be the Future of Microsoft Exclusives